Introduction: The aim of the study was to compare the feasibility and safety of endoscopic thyroid lobectomy via axillary-breast-shoulder approach (ET via ABS) with a conventional open thyroid lobectomy (OT). Methods:...Introduction: The aim of the study was to compare the feasibility and safety of endoscopic thyroid lobectomy via axillary-breast-shoulder approach (ET via ABS) with a conventional open thyroid lobectomy (OT). Methods: From November 2014 to December 2015, 20 patients with unilateral benign thyroid nodules were treated with ET via ABS and another 20 patients were treated with an OT. We analyzed the clinical characteristics postoperative complications, pain, and patient satisfaction. Results: No statistically significant differences occurred between groups except the mean ages of the OT group and the ET via ABS group were 55 and 44 years, respectively (p = 0.015). The mean operative time was almost the same in both groups (116 min in the OT group and 114 min in the ET via ABS group). Blood loss was significantly higher in the OT group than in the ET via ABS group (p = 0.042) but postoperative drainage was detected more in the ET via ABS group (p p = 0.026). The hospital stay was three days in OT group and four days in ET via ABS group (p = 0.909). Postoperative complications such as hematoma, hoarseness, dysphagia, and prolonged subcutaneous emphysema were detected only in the ET via ABS group but without statistical difference. More patients were “very satisfied” with the treatment in the ET via ABS group than in the OT group. Conclusion: The ET via ABS is as safe and effective as the OT for patients with unilateral thyroid nodules. With less early postoperative pain and higher patient satisfaction, this endoscopic thyroidectomy approach should be considered in patients who concern about cosmetic results.展开更多
目的探讨Delta大通道脊柱内镜下单侧入路双侧减压技术治疗胸椎黄韧带骨化症的临床疗效。方法回顾性分析2019年8月至2022年1月潍坊市人民医院采用Delta大通道脊柱内镜治疗的13例胸椎黄韧带骨化症患者,其中男6例,女7例;年龄55~69岁,平均(6...目的探讨Delta大通道脊柱内镜下单侧入路双侧减压技术治疗胸椎黄韧带骨化症的临床疗效。方法回顾性分析2019年8月至2022年1月潍坊市人民医院采用Delta大通道脊柱内镜治疗的13例胸椎黄韧带骨化症患者,其中男6例,女7例;年龄55~69岁,平均(62.62±4.01)岁。记录患者基本信息及围手术期相关指标,并在术后1个月、6个月进行随访,记录术前术后改良日本骨科协会评分(modified Japanese orthopaedic association score,mJOA)、美国脊髓损伤协会(American spinal injury association,ASIA)感觉评分(ASIA sense score,ASS)和双下肢运动评分(ASIA motor score,AMS)变化情况。以mJOA评分计算术后6个月随访时的改善率(recover rate,RR)及优良率,对RR与性别、年龄、术前mJOA评分、影像学分型及病程进行相关性分析。结果平均手术时间为(108.46±16.12)min,平均出血量(23.46±7.47)mL,平均住院时间(6.08±0.86)d。术后随访时间为6~35个月,平均(16.77±9.33)个月,术后1个月及6个月随访时,mJOA、ASS、AMS评分均优于术前(P<0.05),平均RR为(55.69±19.73)%,优良率为69.23%。RR与术前病程呈负相关(P<0.001),与术前mJOA评分呈正相关(P=0.029),与性别、年龄、影像学分型均无明显相关性(P>0.05)。结论Delta大通道脊柱内镜技术治疗胸椎黄韧带骨化症安全可靠,具有术后恢复快、创伤小、出血量少等优势,短期效果良好。展开更多
目的基于Meta分析方法探讨弯角椎体成形术(PCVP)对骨质疏松性椎体压缩骨折(OVCF)的疗效和安全性。方法通过计算机检索PubMed、Cochrane Library、Web of science、中国知网、万方数据库中关于PCVP、经皮椎体成形术(PVP)治疗OVCF的随机...目的基于Meta分析方法探讨弯角椎体成形术(PCVP)对骨质疏松性椎体压缩骨折(OVCF)的疗效和安全性。方法通过计算机检索PubMed、Cochrane Library、Web of science、中国知网、万方数据库中关于PCVP、经皮椎体成形术(PVP)治疗OVCF的随机对照试验(RCT)或回顾性队列研究(RCS)文献,检索时间为建库至2023年9月13日。根据纳入与排除标准筛选文献,进行Meta分析,结局指标包括术后视觉模拟评分法(VAS)评分、术后Oswestry功能障碍指数(ODI)评分、术后Cobb角、术后椎体高度、手术时间、术中透视次数、骨水泥注入量、骨水泥椎体分布优良率、骨水泥渗漏率、再发骨折率。结果本研究最终纳入20篇文献进行Meta分析,包括12篇RCT文献和8篇RCS文献。与PVP组比较,PCVP组术后VAS评分更低(MD=-0.15,95%CI:-0.18~-0.11,P<0.00001),术后ODI评分更低(MD=-1.63,95%CI:-3.06~-0.19,P=0.03),手术时间更短(MD=-7.15,95%CI:-10.74~-3.56,P<0.0001),术中透视次数更少(MD=-3.40,95%CI:-5.71~-1.10,P=0.004),骨水泥椎体分布优良率更高(OR=5.84,95%CI:3.58~9.51,P<0.00001),骨水泥渗漏率更低(OR=0.31,95%CI:0.23~0.42,P<0.00001),差异均有统计学意义;PCVP组术后Cobb角、术后椎体高度、骨水泥注入量和再发骨折率与PVP组比较,差异无统计学意义(P>0.05)。结论相较于PVP,PCVP对OVCF具有更好的疗效与安全性,可减轻疼痛程度,缩短手术时间,减少术中透视次数,降低骨水泥渗漏率,提升骨水泥椎体分布优良率,改善脊柱功能,若条件允许,建议选用PCVP治疗OVCF。展开更多
文摘Introduction: The aim of the study was to compare the feasibility and safety of endoscopic thyroid lobectomy via axillary-breast-shoulder approach (ET via ABS) with a conventional open thyroid lobectomy (OT). Methods: From November 2014 to December 2015, 20 patients with unilateral benign thyroid nodules were treated with ET via ABS and another 20 patients were treated with an OT. We analyzed the clinical characteristics postoperative complications, pain, and patient satisfaction. Results: No statistically significant differences occurred between groups except the mean ages of the OT group and the ET via ABS group were 55 and 44 years, respectively (p = 0.015). The mean operative time was almost the same in both groups (116 min in the OT group and 114 min in the ET via ABS group). Blood loss was significantly higher in the OT group than in the ET via ABS group (p = 0.042) but postoperative drainage was detected more in the ET via ABS group (p p = 0.026). The hospital stay was three days in OT group and four days in ET via ABS group (p = 0.909). Postoperative complications such as hematoma, hoarseness, dysphagia, and prolonged subcutaneous emphysema were detected only in the ET via ABS group but without statistical difference. More patients were “very satisfied” with the treatment in the ET via ABS group than in the OT group. Conclusion: The ET via ABS is as safe and effective as the OT for patients with unilateral thyroid nodules. With less early postoperative pain and higher patient satisfaction, this endoscopic thyroidectomy approach should be considered in patients who concern about cosmetic results.
文摘目的探讨Delta大通道脊柱内镜下单侧入路双侧减压技术治疗胸椎黄韧带骨化症的临床疗效。方法回顾性分析2019年8月至2022年1月潍坊市人民医院采用Delta大通道脊柱内镜治疗的13例胸椎黄韧带骨化症患者,其中男6例,女7例;年龄55~69岁,平均(62.62±4.01)岁。记录患者基本信息及围手术期相关指标,并在术后1个月、6个月进行随访,记录术前术后改良日本骨科协会评分(modified Japanese orthopaedic association score,mJOA)、美国脊髓损伤协会(American spinal injury association,ASIA)感觉评分(ASIA sense score,ASS)和双下肢运动评分(ASIA motor score,AMS)变化情况。以mJOA评分计算术后6个月随访时的改善率(recover rate,RR)及优良率,对RR与性别、年龄、术前mJOA评分、影像学分型及病程进行相关性分析。结果平均手术时间为(108.46±16.12)min,平均出血量(23.46±7.47)mL,平均住院时间(6.08±0.86)d。术后随访时间为6~35个月,平均(16.77±9.33)个月,术后1个月及6个月随访时,mJOA、ASS、AMS评分均优于术前(P<0.05),平均RR为(55.69±19.73)%,优良率为69.23%。RR与术前病程呈负相关(P<0.001),与术前mJOA评分呈正相关(P=0.029),与性别、年龄、影像学分型均无明显相关性(P>0.05)。结论Delta大通道脊柱内镜技术治疗胸椎黄韧带骨化症安全可靠,具有术后恢复快、创伤小、出血量少等优势,短期效果良好。
文摘目的基于Meta分析方法探讨弯角椎体成形术(PCVP)对骨质疏松性椎体压缩骨折(OVCF)的疗效和安全性。方法通过计算机检索PubMed、Cochrane Library、Web of science、中国知网、万方数据库中关于PCVP、经皮椎体成形术(PVP)治疗OVCF的随机对照试验(RCT)或回顾性队列研究(RCS)文献,检索时间为建库至2023年9月13日。根据纳入与排除标准筛选文献,进行Meta分析,结局指标包括术后视觉模拟评分法(VAS)评分、术后Oswestry功能障碍指数(ODI)评分、术后Cobb角、术后椎体高度、手术时间、术中透视次数、骨水泥注入量、骨水泥椎体分布优良率、骨水泥渗漏率、再发骨折率。结果本研究最终纳入20篇文献进行Meta分析,包括12篇RCT文献和8篇RCS文献。与PVP组比较,PCVP组术后VAS评分更低(MD=-0.15,95%CI:-0.18~-0.11,P<0.00001),术后ODI评分更低(MD=-1.63,95%CI:-3.06~-0.19,P=0.03),手术时间更短(MD=-7.15,95%CI:-10.74~-3.56,P<0.0001),术中透视次数更少(MD=-3.40,95%CI:-5.71~-1.10,P=0.004),骨水泥椎体分布优良率更高(OR=5.84,95%CI:3.58~9.51,P<0.00001),骨水泥渗漏率更低(OR=0.31,95%CI:0.23~0.42,P<0.00001),差异均有统计学意义;PCVP组术后Cobb角、术后椎体高度、骨水泥注入量和再发骨折率与PVP组比较,差异无统计学意义(P>0.05)。结论相较于PVP,PCVP对OVCF具有更好的疗效与安全性,可减轻疼痛程度,缩短手术时间,减少术中透视次数,降低骨水泥渗漏率,提升骨水泥椎体分布优良率,改善脊柱功能,若条件允许,建议选用PCVP治疗OVCF。
